Vaccines' Payback In Pounds

摘要

In-depth trials conducted at Kansas State University show the enduring effectiveness of circovirus vaccines. I early completing their second year of use, commercial circovirus vaccines continue to be intensely tested by the research team at Kansas State University (KSU). Vaccines have excelled in virtually all trials. Researcher Steve Dritz, DVM, summarizes some of the group's major findings of trials conducted at research farms and in commercial herds: The vaccines continue to clearly reduce mortality in infected pigs. The vaccines improve growth rates in approximately 85% of pigs in the population that don't even show clinical signs of porcine circovirus type 2 (PCV2).